| For: | Rambaran N, Islam MS. Decoding androgen excess in polycystic ovary syndrome: Roles of insulin resistance and other key intraovarian and systemic factors. World J Diabetes 2025; 16(7): 108789 [PMID: 40697592 DOI: 10.4239/wjd.v16.i7.108789] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v16/i7/108789.htm |
| Number | Citing Articles |
| 1 |
Yuhui Wang, Xitong Liu, Zhi Li, Ahui Kang, Yixuan Bai, Yang Wang, Yan Liu, Chujun Zhang, Jiaqi Yang, Qingqing Cai, Yi Feng, Huan Yi, Mengyu Zhang, Feifei Zhang, Haiou Liu, Congjian Xu. Oligofructose alleviates hyperandrogenism in polycystic ovary syndrome through gut microbiota-derived bile acids. Journal of Advanced Research 2026; doi: 10.1016/j.jare.2026.04.036
|
| 2 |
Xiujia Sun, Yuanze Gao, Lei Zhang, Wangtao Li, Ailing Ning, Kumar Ganesan, Zhanhua Li, Xiaoyue Zhang, Hongbing Liu, Lihua Wang, Yingmei Fu, Lanying Liu, Jianping Chen. Traditional Chinese medicine for antipsychotic-induced hyperprolactinemia: A comprehensive review of ethnopharmacological foundations, mechanistic insights, and network pharmacology perspectives. Journal of Ethnopharmacology 2026; 366 doi: 10.1016/j.jep.2026.121623
|
| 3 |
Jyolsna Ponnaratta Kunhiraman, Reyon Dcunha, Vanishree Vasave Madhvacharya, Vani Lakshmi R, Ganesh Venkatraman, Nidhi Rajesh Shah, Anujith Kumar, Satish Kumar Adiga, Nagarajan Kannan, Guruprasad Kalthur, Rina Meidan. Impact of repeated ovulation induction and superovulation on ovarian reserve and early embryo development in obese and PCOS-like mouse models. Reproduction, Fertility and Development 2026; 38(8) doi: 10.1071/RD26037
|
| 4 |
K. Gunasekaran, M. Rajalakshmi. Biomarker-driven diagnostics and personalized treatment in polycystic ovary syndrome. Clinica Chimica Acta 2026; doi: 10.1016/j.cca.2026.121173
|
| 5 |
Xiao-Juan Zhu, Wenting Xu, Ai-Fang Lu. Endocrine-disrupting chemicals and polycystic ovary syndrome: A systems toxicology perspective on mechanistic pathways. Reproductive Toxicology 2026; 142 doi: 10.1016/j.reprotox.2026.109233
|
| 6 |
Wanqiu Yang, Lin Yin, Qingling Xie, Moyao Tan, Yunzhu Liu, Jili Xu, Jie Wu. Harnessing probiotic-metformin synergy: targeting the gut-microbiota metabolism axis to ameliorate polycystic ovary syndrome. Frontiers in Nutrition 2026; 12 doi: 10.3389/fnut.2025.1699600
|
| 7 |
Mohammed Hamsho, Wijdan Shkorfu, Meriem Bensaoua, Carlos Eduardo Carvalho Martins, Hale Hacıbayram, Abdulmannan Fadel, Yazan Ranneh. Effects of probiotic and metformin co-administration versus metformin monotherapy on anthropometric measurements, hormones, and glucolipid profile in women with polycystic ovary syndrome: a systematic review and meta-analysis. Frontiers in Endocrinology 2026; 17 doi: 10.3389/fendo.2026.1802369
|
| 8 |
Charalampos Voros, Georgios Papadimas, Despoina Mavrogianni, Aristotelis-Marios Koulakmanidis, Diamantis Athanasiou, Kyriakos Bananis, Antonia Athanasiou, Aikaterini Athanasiou, Ioannis Papapanagiotou, Dimitrios Vaitsis, Charalampos Tsimpoukelis, Maria Anastasia Daskalaki, Vasileios Topalis, Marianna Theodora, Nikolaos Thomakos, Fotios Chatzinikolaou, Panagiotis Antsaklis, Dimitrios Loutradis, Evangelos Menenakos, Georgios Daskalakis. Molecular Signatures of Obesity-Associated Infertility in Polycystic Ovary Syndrome: The Emerging Role of Exosomal microRNAs and Non-Coding RNAs. Genes 2025; 16(9) doi: 10.3390/genes16091101
|
| 9 |
Sumayyah Subakathulla, Norwin Manoj, Azima Muzzammil Patanwala, Prasanna Appiya Premvignesh, Yamen Maher Alobaid, Ankit Majie, Bapi Gorain, Sulagna Dutta, Pallav Sengupta, Israel Maldonado Rosas, Shubhadeep Roychoudhury. Redox-endocrine triad in PCOS: can vitamin D, myo-inositol, and melatonin synergize as bioactive cocktails?. Frontiers in Endocrinology 2026; 17 doi: 10.3389/fendo.2026.1825853
|
| 10 |
|
| 11 |
R.E. Akhigbe, A.I. Omole, P.A. Oyedokun, A.F. Odetayo, E.A. Ashamu, T.M. Akhigbe. Heat stress and human reproduction: effects and pathogenesis. Journal of Thermal Biology 2025; 134 doi: 10.1016/j.jtherbio.2025.104302
|
| 12 |
黎明 孟. Research Progress on the Treatment of Obesity-Related Polycystic Ovary Syndrome with Traditional Chinese and Western Medicine. Journal of Clinical Personalized Medicine 2026; 5(02) doi: 10.12677/jcpm.2026.52111
|
| 13 |
Arifa Mustika, Era Gorica, Dante Saksono Harbuwono, Eighty Mardiyan Kurniawati, Edwin Hadinata, Amal Arifi Hidayat, Salmon Charles Pardomuan Tua Siahaan, Hendy Hendarto, Antonello Santini, Fahrul Nurkolis. Algae-Derived Bioactives Reprogram the Gut–SIRT1–Kisspeptin Axis in Polycystic Ovary Syndrome. Marine Drugs 2026; 24(5) doi: 10.3390/md24050185
|